RT Journal Article
SR Electronic
T1 Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004291corr1
DO 10.1136/jitc-2021-004291corr1
VO 10
IS 6
YR 2022
UL http://jitc.bmj.com/content/10/6/e004291corr1.abstract